Glaucoma drainage implants, sometimes called tube shunts, carry a broad range of possible side effects that span from mild, self-resolving issues in the first days after surgery to serious long-term complications that can threaten vision. Overall complication rates reported in major comparative trials run from roughly half to two-thirds of patients experiencing at least one complication over several years of follow-up, though many of those are minor and manageable.1PubMed. The Ahmed versus Baerveldt study: three-year treatment outcomes That sounds alarming on its face, but the context matters: these devices are typically reserved for eyes that have already failed other treatments or carry a high risk of failure with standard filtering surgery, so the alternative is often progressive, irreversible vision loss from uncontrolled glaucoma.
What Happens in the First Days and Weeks
The early postoperative period is when the eye is most unstable, and the complications that show up tend to involve pressure being too low rather than too high. Hypotony, meaning the eye pressure drops below normal, is the most common early concern. When pressure falls too far, the front chamber of the eye can become shallow or even flat. A pooled analysis of Ahmed glaucoma valve cases found that a shallow anterior chamber developed in about 7% of implants, typically appearing around three days after surgery and resolving within about six days. Nearly half of those cases were associated with hypotony, and about a quarter involved fluid collecting behind the retina, known as choroidal detachment.2PubMed Central. Effect of immediate shallow anterior chamber after Ahmed glaucoma valve implantation on intermediate-term intraocular pressure control Risk factors for this early shallowing include younger age, nearsightedness, and fewer prior eye surgeries; surgeons sometimes partially ligate (tie off) the tube during the operation to slow drainage and reduce this risk.3PubMed. Risk factors of shallow anterior chamber other than hypotony after Ahmed glaucoma valve implant
Choroidal effusions, where fluid collects under the choroid layer at the back of the eye, are fairly common and usually harmless. In one large series of Baerveldt implants, about one in five eyes developed effusions that needed nothing more than observation. A smaller fraction, around 2%, grew large enough to need surgical drainage.4JAMA Ophthalmology. Complications of Baerveldt Glaucoma Drainage Implants More worrisome is delayed suprachoroidal hemorrhage, where actual bleeding rather than just fluid accumulates behind the retina. Across more than 2,200 glaucoma procedures, this happened in about 2.8% of valved tube shunts and 7.1% of nonvalved ones, compared with 1.5 to 2.4% for trabeculectomies.5PubMed. Delayed suprachoroidal hemorrhage after glaucoma filtration procedures While it can be sight-threatening, conservative management with medications and pressure control sometimes leads to good outcomes even when the hemorrhage occurs dramatically, such as during a routine pressure check the day after surgery.6Duke Journal of Case Reports in Ophthalmology. Delayed suprachoroidal hemorrhage during anterior chamber decompression one day following tube shunt implantation
Other early complications include tube blockage from iris tissue or vitreous gel plugging the opening (around 5% in one series), blood in the front of the eye, and occasionally misdirection of fluid within the eye.4JAMA Ophthalmology. Complications of Baerveldt Glaucoma Drainage Implants
The Hypertensive Phase
One of the more frustrating complications is something of a paradox: after implanting a device specifically to lower eye pressure, the pressure spikes back up. This “hypertensive phase” typically starts a few weeks after surgery and can last months. It occurs in roughly half of all glaucoma drainage device cases regardless of the device used. In a study that tracked Ahmed, Baerveldt, and Molteno implants, about 53% of patients developed this phase, with rates hovering around 50 to 55% across all three device types.7PubMed Central. Factors related to hypertensive phase after glaucoma drainage device implantation The pressure rise is thought to result from the body’s wound-healing response forming a thickened capsule around the plate of the device. It often responds to glaucoma eye drops, and in many cases the pressure eventually settles back down. But the hypertensive phase is a major reason why patients should not expect to throw away their eye drops immediately after tube surgery.
Conjunctival Erosion and Tube Exposure
The tube of a drainage implant passes from inside the eye, under a patch of tissue on the surface, and connects to a plate that sits on the outside of the eyeball underneath the conjunctiva (the clear membrane covering the white of the eye). Over months or years, that tube can work its way through the overlying tissue and become exposed. This is called conjunctival erosion, and it is one of the more consequential late complications because an exposed tube creates a direct pathway for bacteria to enter the eye.
In a study of 306 Ahmed valve implants, conjunctival erosion occurred in about 7.5% of eyes. Most erosions happened over the tube itself rather than the plate. Eyes without a natural lens (aphakic eyes) had a dramatically higher risk, and uveitic glaucoma was another strong predictor. Prolonged use of steroid eye drops after surgery also increased erosion risk substantially.8PubMed Central. Factors Associated with Conjunctival Erosions after Ahmed Glaucoma Valve Implantation The patch graft material used to cover the tube during surgery matters, too. One study comparing human donor sclera to bovine pericardium found that about 14% of eyes with bovine pericardium developed tube exposure, compared with none in the donor sclera group.9PubMed Central. Donor sclera versus bovine pericardium as patch graft material in glaucoma implant surgery and the impact of a drainage suture Other graft materials, including locally sourced pericardium and preserved sclera, have been compared as well, with overall tube exposure rates around 3% and no single material emerging as clearly superior across all studies.10PubMed Central. Comparison of Locally Sourced Pericardium and Other Conventional Patch Graft Materials in a Glaucoma Drainage Device Surgery
Infection and Endophthalmitis
The most feared complication of any intraocular surgery is endophthalmitis, a severe infection inside the eye. With drainage implants, the risk is closely tied to tube exposure. Among 49 cases of implant exposure in one study, about 16% were associated with an intraocular infection. Implants placed in the lower part of the eye carried a much higher infection risk when exposed (about 42%) compared with those placed superiorly (about 8%).11PubMed Central. Glaucoma Drainage Devices: Risk of Exposure and Infection The bacterium most frequently identified in these infections is Streptococcus pneumoniae. Immediate injection of antibiotics into the eye is the standard first response, but the infection still tends to cause lasting damage: on average, vision was significantly worse at final follow-up compared with baseline in a multi-center study of implant-related endophthalmitis.12PubMed. Infectious and Sterile Endophthalmitis in Eyes with Glaucoma Drainage Device from Two Large Ophthalmic Institutions Two-thirds of those endophthalmitis cases had a visible device exposure on examination, reinforcing how important it is for patients with tube shunts to report any redness, pain, or visible hardware to their ophthalmologist promptly.
Corneal Endothelial Cell Loss
The cornea, the clear window at the front of the eye, is lined on its inner surface by a single layer of endothelial cells that keep it transparent. These cells do not regenerate well in adults, and having a silicone tube sitting in the front chamber of the eye accelerates their loss. Several mechanisms have been proposed: turbulent fluid flow at the tube’s tip, chronic low-grade inflammation, intermittent contact between the tube and the cornea, and a general foreign-body response to the silicone material.13Scientific Reports. Corneal endothelial cell changes and surgical results after Ahmed glaucoma valve implantation: ciliary sulcus versus anterior chamber tube placement If enough cells are lost, the cornea becomes hazy and swollen, a condition called corneal decompensation. Placing the tube behind the iris in the ciliary sulcus rather than in the front chamber increases the distance from the cornea and may help protect those cells, though the overall complication rates at three months were similar regardless of tube placement location in at least one comparative study.14PubMed Central. Outcomes of Anterior Chamber, Sulcus, and Pars Plana Glaucoma Drainage Device Placement in Glaucoma Patients A meta-analysis comparing pars plana placement (behind the lens, through the back part of the eye) with anterior chamber placement also found no significant differences in overall complications or corneal failure between the two approaches.15PubMed Central. Comparison of pars plana with anterior chamber glaucoma drainage device implantation for glaucoma: a meta-analysis
Double Vision and Eye Movement Problems
Drainage devices are physically large by ophthalmic standards. The plate is sewn to the eyeball, usually in one of the spaces between the eye muscles, and the fibrous capsule that forms around it can restrict the eye’s ability to rotate. This restriction tends to limit movement away from the side where the implant sits and can pull the eye toward the implant, resulting in misalignment and double vision.16JAMA Ophthalmology. Surgical Treatment of Strabismus Secondary to Glaucoma Drainage Device The exact cause is not fully pinned down but likely involves the bulk of the device, the surrounding scar tissue, and changes in how the eye muscles function from surgical manipulation and postoperative inflammation.17PubMed Central. Binocular disturbance after glaucoma drainage device implantation Strabismus surgery can sometimes correct the problem, but it is technically challenging because the scarring makes the muscles less predictable. For patients who already have compromised binocular vision, this is worth discussing with the surgeon beforehand.
Bleb Encapsulation and Why Devices Fail
The most common reason a glaucoma drainage device eventually stops working is that the body walls it off. The plate of the implant sits underneath the conjunctiva, and fluid draining out of the eye is supposed to soak through the surrounding tissue and be absorbed. But the body treats the plate as a foreign object and forms a fibrous capsule around it. If that capsule becomes too thick and impermeable, it blocks fluid flow and eye pressure climbs back up.18PubMed Central. Altered Expression of Fibrosis Genes in Capsules of Failed Ahmed Glaucoma Valve Implants
Research on these failed capsules has found overactive scarring signals and reduced levels of protective molecules that normally keep tissue flexible, which together create a dense barrier that resists fluid passage.19PubMed Central. Histopathologic and immunohistochemical features of capsular tissue around failed Ahmed glaucoma valves This is why researchers are experimenting with modified device surfaces. In animal models, plates coated with heparin or given a textured micro-pattern produced thinner capsules compared with standard devices, suggesting that future implant designs might resist encapsulation more effectively.20PubMed Central. Effect of Novel Design Modifications on Fibrotic Encapsulation: An In Vivo Glaucoma Drainage Device Study in a Rabbit Model
Ahmed Versus Baerveldt Implants
The two most commonly used drainage devices, the Ahmed and Baerveldt implants, differ in a key way: the Ahmed has a built-in valve that restricts flow immediately after surgery, while the Baerveldt is an open tube that the surgeon temporarily ties shut and allows to open weeks later. This design difference shapes their complication profiles.
The Ahmed tends to produce fewer early complications (around 12% versus 23% with the Baerveldt), but both devices carry substantial late complication rates in the range of 26 to 31%.21PubMed Central. Comparison of complications after Ahmed versus Baerveldt implant in glaucoma patients: one year follow-up Three-year data from the Ahmed versus Baerveldt (AVB) trial showed that overall complication rates were not statistically different between the two, but vision-threatening complications related to hypotony, specifically very low pressure causing serious harm, were significantly higher with the Baerveldt (6% versus 0%).1PubMed. The Ahmed versus Baerveldt study: three-year treatment outcomes The trade-off is that the Baerveldt generally achieves lower final pressures and requires fewer medications, but it has a higher risk of the dangerous early pressure drops. At five years, the Ahmed had a higher cumulative failure rate (49%) compared to the Baerveldt (37%), and both groups saw significant visual acuity decline over that period, with roughly 42 to 44% of patients losing two or more lines of vision.22PubMed Central. Glaucoma Drainage Device Implantation, Outcomes, and Complications
Separate long-term data showed a similar pattern: at three years, cumulative failure was 51% with the Ahmed and 34% with the Baerveldt, and the Baerveldt group used fewer medications on average.23Survey of Ophthalmology. Glaucoma drainage devices: a systematic literature review and current controversies In short, the Baerveldt tends to work better at lowering pressure in the long run but carries more risk upfront, particularly from hypotony. Which device is preferred depends heavily on the individual eye’s condition and risk tolerance.
Device Materials and the Body’s Response
The material the implant plate is made from influences outcomes. Early Ahmed valves used polypropylene plates, while newer versions use silicone. A direct comparison found that polypropylene plates were associated with more complications, including a higher rate of Tenon’s cyst (a fluid-filled bleb that forms over the plate and can raise pressure).24PubMed. Comparison of polypropylene and silicone Ahmed Glaucoma Valves Materials research has also explored porous polyethylene, which allows tissue to grow into the device rather than simply encapsulating it. The idea is that integration with surrounding tissue reduces the kind of mechanical shifting that can worsen inflammation and erosion over time.25Advances in Ophthalmology Practice and Research. Development and material characteristics of glaucoma surgical implants This is still an evolving area, and no material has eliminated the encapsulation problem entirely, but the trend in newer devices is clearly toward more biocompatible surfaces.
Quality of Life After Implant Surgery
Side effects and complication rates tell only part of the story. What patients care about is how they feel and function afterward. The Tube Versus Trabeculectomy (TVT) study, one of the largest comparative trials in glaucoma surgery, found that tube shunt surgery and trabeculectomy had a similar impact on vision-related quality of life as measured by a standardized questionnaire.26PubMed. Quality of Life in the Tube Versus Trabeculectomy Study A separate study using multiple quality-of-life instruments found that patients with drainage devices scored higher on one scale than patients on medical therapy alone, comparable on another, and similar to trabeculectomy patients on a surgery-specific satisfaction questionnaire.27Indian Journal of Ophthalmology. Quality of life in glaucoma patients: Comparison of medical therapy, trabeculectomy, and glaucoma drainage device surgery The instruments can give somewhat mixed signals, which reflects the real complexity of the patient experience: freedom from eye drops is a relief, but surgical recovery is a hassle, and lingering side effects like dry eye or double vision can undercut the gains. In general, though, patients who genuinely need tube surgery tend to report quality of life at least comparable to the alternatives.
Eyes with Prior Vitreoretinal Surgery
Patients who have already had retinal surgery, such as vitrectomy or scleral buckle, face a higher risk of developing glaucoma afterward and also tend to have worse outcomes with standard filtering procedures. Drainage devices are frequently the preferred option in these eyes precisely because the anatomy has been altered in ways that make a trabeculectomy less likely to succeed.28PubMed Central. Glaucoma management after vitreoretinal surgeries The complication profile in these patients can differ from the general population: the conjunctiva may be more scarred, the eye may already have compromised blood flow, and the vitreous cavity has been altered in ways that change fluid dynamics. If you are being offered a tube shunt after retinal surgery, understanding that your baseline risk is already elevated can help set realistic expectations.
Blood Thinners and Surgical Timing
A practical concern that often comes up before any eye surgery is whether to stop blood-thinning medications. Anticoagulants and antiplatelet drugs increase the risk of bleeding during and after surgery, which is especially relevant given that tube shunts already carry a risk of suprachoroidal hemorrhage. However, stopping these medications raises the risk of stroke or heart attack, depending on why you are taking them. Current guidance emphasizes that the decision should be individualized based on each patient’s specific reason for anticoagulation and the particular surgical procedure planned.29Journal of Glaucoma. Management of Anticoagulation and Antiplatelet Therapy in Glaucoma Surgery This is a conversation you should have with both your eye surgeon and your cardiologist or primary care doctor well before the procedure is scheduled. In many cases, the ophthalmologist may proceed without stopping the medication, accepting a slightly higher hemorrhage risk to avoid the cardiovascular danger of interrupting the drug.
Children and Drainage Implants
Glaucoma drainage devices are increasingly used in pediatric patients, sometimes as the first surgical option rather than a backup after other procedures fail.30PubMed Central. Glaucoma drainage devices in children: an updated review Children’s eyes present unique challenges: they are smaller, still growing, and mount a much more aggressive healing response than adult eyes. That vigorous healing makes encapsulation and device failure particularly common, and the lifetime of follow-up and potential reoperations is much longer. Tube exposure is also a concern because children are less likely to notice or report early warning signs. Pediatric glaucoma surgery is a subspecialty unto itself, and the decision to use a drainage implant in a child involves weighing these heightened risks against the alternatives, which in young children with refractory glaucoma are often limited.